Stock Market Reviews

ANIK (Anika Therapeutics, Inc.) News

Get the latest news, insights, and market updates on ANIK (Anika Therapeutics, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Orthopedic Digit Implants Market Report 2025-2033, with Profiles of Extremity Medical, Stryker, Zimmer, Smith & Nephew, Depuy, Arthrex, Acumed, Anika Therapeutics, VILEX, and Paragon 28
  Key opportunities in the orthopedic digit implants market include rising demand due to increasing prevalence of arthritis, technological advancements in biomaterials and implant design, and strategic partnerships among industry players. Additionally, growing preference for minimally invasive procedures and new market entrants offer significant potential. Orthopedic Digit Implants Market Orthopedic Digit Implants Market Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Orthopedic Digit Implants Mark
  Oct 8, 2025 - $ANIK
• Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?
  Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
  Sep 19, 2025 - $ANIK
• Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $9.15, which equaled the closing price of common stock on the Nasdaq Global Select Market on
  Sep 5, 2025 - $ANIK
• Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?
  The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  Aug 29, 2025 - $ANIK
• Anika (ANIK) Upgraded to Buy: Here's What You Should Know
  Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
  Aug 20, 2025 - $ANIK
• Anika Therapeutics Second Quarter 2025 Earnings: Beats Expectations
  Anika Therapeutics ( NASDAQ:ANIK ) Second Quarter 2025 Results Key Financial Results Revenue: US$28.2m (down 33% from...
  Aug 1, 2025 - $ANIK
• Anika: Q2 Earnings Snapshot
  ANIK) on Wednesday reported a loss of $4 million in its second quarter. On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 28 cents. Losses, adjusted for one-time gains and costs, were 13 cents per share.
  Jul 30, 2025 - $ANIK
• Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
  Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function Hyalofast showed statistically significant improvements over microfracture in pre-defined secondary endpoints and other measures that align with prior FDA approvals for cartilage repair products Hyalofast has been used to treat over 35,000 patients in more than 35 countries outside the U.S. since 200
  Jul 30, 2025 - $ANIK
• Anika Reports Second Quarter 2025 Financial Results
  Regenerative Solutions revenue up 41% with Integrity™ Implant System ahead of expectations and continued strong Hyalofast® growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast® clinical trial which did not meet pre-specified co-primary end points; Hyalofast demonstrated statistically significant improvements in pre-defined secondary endpoints and other measures; Company plans to file the final PMA module
  Jul 30, 2025 - $ANIK
• Sector Update: Health Care Stocks Decline in Late Afternoon Trading
  Health care stocks decreased late Wednesday afternoon with the NYSE Health Care Index dropping 0.7%
  Jul 30, 2025 - $ANIK